vs
Side-by-side financial comparison of AMICUS THERAPEUTICS, INC. (FOLD) and Westrock Coffee Co (WEST). Click either name above to swap in a different company.
Westrock Coffee Co is the larger business by last-quarter revenue ($339.5M vs $185.2M, roughly 1.8× AMICUS THERAPEUTICS, INC.). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -6.6%, a 7.6% gap on every dollar of revenue. On growth, Westrock Coffee Co posted the faster year-over-year revenue change (48.3% vs 23.7%). Westrock Coffee Co produced more free cash flow last quarter ($27.8M vs $16.0M). Over the past eight quarters, Westrock Coffee Co's revenue compounded faster (32.8% CAGR vs 29.5%).
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
Westrock Coffee Co is a global integrated coffee, tea and functional beverage solutions provider. It sources, roasts, manufactures and distributes coffee products, ready-to-drink beverages and custom formulations for retail, foodservice and commercial clients across North America and other key markets.
FOLD vs WEST — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $185.2M | $339.5M |
| Net Profit | $1.7M | $-22.6M |
| Gross Margin | 85.7% | 11.5% |
| Operating Margin | 8.6% | -2.6% |
| Net Margin | 0.9% | -6.6% |
| Revenue YoY | 23.7% | 48.3% |
| Net Profit YoY | -88.5% | 8.3% |
| EPS (diluted) | $0.00 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $185.2M | $339.5M | ||
| Q3 25 | $169.1M | $354.8M | ||
| Q2 25 | $154.7M | $280.9M | ||
| Q1 25 | $125.2M | $213.8M | ||
| Q4 24 | $149.7M | $229.0M | ||
| Q3 24 | $141.5M | $220.9M | ||
| Q2 24 | $126.7M | $208.4M | ||
| Q1 24 | $110.4M | $192.5M |
| Q4 25 | $1.7M | $-22.6M | ||
| Q3 25 | $17.3M | $-19.1M | ||
| Q2 25 | $-24.4M | $-21.6M | ||
| Q1 25 | $-21.7M | $-27.2M | ||
| Q4 24 | $14.7M | $-24.6M | ||
| Q3 24 | $-6.7M | $-14.3M | ||
| Q2 24 | $-15.7M | $-17.8M | ||
| Q1 24 | $-48.4M | $-23.7M |
| Q4 25 | 85.7% | 11.5% | ||
| Q3 25 | 88.5% | 11.7% | ||
| Q2 25 | 90.2% | 14.7% | ||
| Q1 25 | 90.7% | 13.6% | ||
| Q4 24 | 90.1% | 16.6% | ||
| Q3 24 | 90.6% | 16.8% | ||
| Q2 24 | 91.1% | 19.9% | ||
| Q1 24 | 87.7% | 19.4% |
| Q4 25 | 8.6% | -2.6% | ||
| Q3 25 | 20.3% | -2.4% | ||
| Q2 25 | -6.1% | -5.3% | ||
| Q1 25 | -6.3% | -6.1% | ||
| Q4 24 | 10.7% | -4.3% | ||
| Q3 24 | 15.3% | -5.8% | ||
| Q2 24 | 11.8% | -7.9% | ||
| Q1 24 | -25.1% | -5.3% |
| Q4 25 | 0.9% | -6.6% | ||
| Q3 25 | 10.2% | -5.4% | ||
| Q2 25 | -15.8% | -7.7% | ||
| Q1 25 | -17.3% | -12.7% | ||
| Q4 24 | 9.8% | -10.7% | ||
| Q3 24 | -4.8% | -6.5% | ||
| Q2 24 | -12.4% | -8.5% | ||
| Q1 24 | -43.9% | -12.3% |
| Q4 25 | $0.00 | $-0.22 | ||
| Q3 25 | $0.06 | $-0.20 | ||
| Q2 25 | $-0.08 | $-0.23 | ||
| Q1 25 | $-0.07 | $-0.29 | ||
| Q4 24 | $0.05 | $-0.26 | ||
| Q3 24 | $-0.02 | $-0.16 | ||
| Q2 24 | $-0.05 | $-0.20 | ||
| Q1 24 | $-0.16 | $-0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $293.5M | $49.9M |
| Total DebtLower is stronger | $392.7M | $444.1M |
| Stockholders' EquityBook value | $274.2M | $-1.9M |
| Total Assets | $949.9M | $1.2B |
| Debt / EquityLower = less leverage | 1.43× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $293.5M | $49.9M | ||
| Q3 25 | $263.8M | $34.0M | ||
| Q2 25 | $231.0M | $44.0M | ||
| Q1 25 | $250.6M | $33.1M | ||
| Q4 24 | $249.9M | $26.2M | ||
| Q3 24 | $249.8M | $22.4M | ||
| Q2 24 | $260.1M | $24.3M | ||
| Q1 24 | $239.6M | $12.6M |
| Q4 25 | $392.7M | $444.1M | ||
| Q3 25 | $392.0M | — | ||
| Q2 25 | $391.3M | — | ||
| Q1 25 | $390.7M | — | ||
| Q4 24 | $390.1M | $393.1M | ||
| Q3 24 | $389.5M | — | ||
| Q2 24 | $388.9M | — | ||
| Q1 24 | $388.4M | — |
| Q4 25 | $274.2M | $-1.9M | ||
| Q3 25 | $230.4M | $11.4M | ||
| Q2 25 | $204.3M | $18.2M | ||
| Q1 25 | $193.6M | $71.4M | ||
| Q4 24 | $194.0M | $97.5M | ||
| Q3 24 | $178.8M | $110.3M | ||
| Q2 24 | $132.5M | $81.5M | ||
| Q1 24 | $130.7M | $91.7M |
| Q4 25 | $949.9M | $1.2B | ||
| Q3 25 | $868.8M | $1.2B | ||
| Q2 25 | $815.3M | $1.2B | ||
| Q1 25 | $789.8M | $1.1B | ||
| Q4 24 | $785.0M | $1.1B | ||
| Q3 24 | $786.6M | $1.1B | ||
| Q2 24 | $749.5M | $1.1B | ||
| Q1 24 | $721.8M | $983.3M |
| Q4 25 | 1.43× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 1.92× | — | ||
| Q1 25 | 2.02× | — | ||
| Q4 24 | 2.01× | 4.03× | ||
| Q3 24 | 2.18× | — | ||
| Q2 24 | 2.93× | — | ||
| Q1 24 | 2.97× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $16.3M | $36.7M |
| Free Cash FlowOCF − Capex | $16.0M | $27.8M |
| FCF MarginFCF / Revenue | 8.6% | 8.2% |
| Capex IntensityCapex / Revenue | 0.2% | 2.6% |
| Cash ConversionOCF / Net Profit | 9.62× | — |
| TTM Free Cash FlowTrailing 4 quarters | $29.8M | $-107.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $16.3M | $36.7M | ||
| Q3 25 | $35.7M | $-26.6M | ||
| Q2 25 | $-26.5M | $-7.0M | ||
| Q1 25 | $7.8M | $-22.1M | ||
| Q4 24 | $-3.9M | $2.8M | ||
| Q3 24 | $-23.0M | $-332.0K | ||
| Q2 24 | $22.7M | $-23.7M | ||
| Q1 24 | $-29.7M | $8.0M |
| Q4 25 | $16.0M | $27.8M | ||
| Q3 25 | $35.3M | $-44.7M | ||
| Q2 25 | $-28.9M | $-27.5M | ||
| Q1 25 | $7.5M | $-63.4M | ||
| Q4 24 | $-4.2M | $-15.4M | ||
| Q3 24 | $-23.3M | $-36.7M | ||
| Q2 24 | $21.6M | $-59.9M | ||
| Q1 24 | $-31.5M | $-60.9M |
| Q4 25 | 8.6% | 8.2% | ||
| Q3 25 | 20.9% | -12.6% | ||
| Q2 25 | -18.7% | -9.8% | ||
| Q1 25 | 6.0% | -29.7% | ||
| Q4 24 | -2.8% | -6.7% | ||
| Q3 24 | -16.5% | -16.6% | ||
| Q2 24 | 17.0% | -28.7% | ||
| Q1 24 | -28.5% | -31.7% |
| Q4 25 | 0.2% | 2.6% | ||
| Q3 25 | 0.2% | 5.1% | ||
| Q2 25 | 1.6% | 7.3% | ||
| Q1 25 | 0.2% | 19.3% | ||
| Q4 24 | 0.2% | 7.9% | ||
| Q3 24 | 0.3% | 16.5% | ||
| Q2 24 | 0.9% | 17.4% | ||
| Q1 24 | 1.6% | 35.8% |
| Q4 25 | 9.62× | — | ||
| Q3 25 | 2.06× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -0.27× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
WEST
| Coffee And Tea | $202.6M | 60% |
| Flavors Extracts And Ingredients | $69.6M | 21% |
| Sustainable Sourcing And Traceability Segments | $66.9M | 20% |
